Allergan

OZURDEX

Manufacturer:

Allergan

Ozurdex HCPCS:

J7312

HCPCS Code Descriptor:

Injection, dexamethasone, intravitreal implant, 0.1 mg

Category:

J Code

Ozurdex NDCs:

00023-3348-07

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ozurdex:

OZURDEX is an Opthalmic drug manufactured by Allergan and administered via the Intraocular route of administration. The J Code: J7312 is aligned to the drug OZURDEX.

Ozurdex is listed under the drug class of corticosteroid. This medication is used to treat certain types of inflammation in the eye and is administered via an intraocular implantation. Ozurdex is a branded medication manufactured by Allergan. Patient assistance programs for this medication can be found through AbbVie.

ACCESS PRICING AND MORE BY REGISTERING

J7312 Added Date:

January 1, 2011

J7312 Effective Date:

January 1, 2011

J7312 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ozurdex billing and coding information.
Ozurdex patient assistance information can be found through the myAbbVie Assist Program at the URL: https://www.abbvie.com/patients/patient-support/patient-assistance/eligibility-criteria.html
OZURDEX prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for OZURDEX. Please check back in a few weeks.